Policy & Regulation
-
New EPA Regulation Sets Temporary Maximum Residue Limits for Kasugamycin in Selected Products
2023-12-20The United States Environmental Protection Agency (EPA) recently issued Regulation No. 2023-27654 on December 18, 2023.
-
The Rise of biological linecides: Saving hundreds of billions of dollars in crop losses caused by nematodes
2023-12-18The Rise of biological linecides: Saving hundreds of billions of dollars in crop losses caused by nematodes
-
China's Active Pharmaceutical Ingredients Industry Analysis - Driving China's Pharmaceutical Industry: Unveiling the Power of National Policies
2023-12-15China's pharmaceutical industry is experiencing a transformative period driven by strategic national policies aimed at fostering high-quality development, enhancing production standards, and promoting environmental sustainability.
-
Setbacks in Cell Therapy: FDA Halts Clinical Trials of Three Biotech's Products
2023-12-15Biotech company SciGene Pharmaceuticals, specializing in cell therapy, revealed that it had received a notice from the U.S. Food and Drug Administration (FDA) on the previous day, ordering the temporary halt of clinical trials for its products CT053, CT04
-
Sirona Biochem Corp to Trademark Anti-aging Molecule as GlycoProteMim
2023-12-13Sirona Biochem has begun the trademarking process through it’s subsidiary, TFChem and is engaging industry experts to plan for commercializing GlycoProteMim.
-
Crystal India acquips Syngenta's herbicide Gramoxone(Paraquat)trademark for use in its market
2023-12-12Crystal India recently announced the acquisition of the herbicide Gramoxone (active ingredient: Paraquat) trademark from Syngenta for use in the Indian market.
-
New EU Regulations for Wine Ingredients and Nutritional Labeling Come Into Effect December 8
2023-12-12Beginning December 8, 2023, the EU will require ingredients and nutrition labeling for wine and wine products.
-
Squalene Market Driven by Demand from Asia-Pacific and the Cosmetic Industry
2023-12-05The global squalene market is expected projected to reach USD 202 million by 2028, at a CAGR of 6.3%, between 2023 and 2028, according to MarketsandMarkets’ latest report [1]. Its size was estimated at USD 141 million in 2022.
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
2023-12-01The U.S. Food and Drug Administration (FDA) recently rolled out additional tools and answers to frequently asked questions (FAQs) to inform stakeholders about Section 204 of the Food Safety Modernization Act (FSMA 204), also known as the Food Traceability
-
EU Declares Safety of Nematophilic Fungus NCIMB 30336 Feed Additive for Herbivores
2023-12-01FEEDAP to deliver a scientific opinion on the safety of the feed additive containing Duddingtonia flagrans NCIMB 30336, known as BioWorma®, for all grazing animals.
-
Better-for-you munch: APAC's Demand for Functional, Fresh, and Flavorful Better-for-You Treats
2023-11-23The better-for-you snacks sector in Asia Pacific will need to step up its focus onproduct functionality and freshness if it is to build on the boom it has enjoyed inrecent years.
-
LipoTrue Unveils Revolutionary Skin Solutions: Col-4-Frag remastered™ and Calisensix™ at in-cosmetics Asia 2023
2023-11-21LipoTrue launched at in-cosmetics Asia 2023, booth R70, two new active ingredients to calm and rejuvenate the skin. A collagen fragment from wild plant proteins as biofactories, which was presented on 7 November through a technical seminar.
-
Solar PV Industry Drives Demand for EVA/POE Particles: Market Analysis and Price Trends
2023-11-20The solar photovoltaic (PV) industry in China has experienced rapid growth, with the installed capacity reaching 129 GW in the first three quarters of 2023, representing a 145% year-on-year increase.
-
IFSAC Unveils 2021 Report: Diverse Food Sources Linked to Salmonellosis Cases
2023-11-20IFSAC 2021 Foodborne Illness Source Attribution Report Shows Salmonellosis Caused by Variety of Foods
-
Repotrectinib (Augtyro™) Receives FDA Approval for ROS1-Positive Non-Small Cell Lung Cancer
2023-11-17Rendin Pharmaceuticals, in partnership with Pfizer Inc., announced that repotrectinib (Augtyro™) has received approval from the U.S. FDA for the treatment of locally advanced or metastatic ROS1-positive non-small cell lung cancer.
-
Surging Demand for High-Protein Products in the Middle East Amidst Active Nutrition and Healthy Aging Boom
2023-11-17Consumers in the Middle East are increasingly looking for protein-richproducts to fulfil various needs, with claims ranging from sportsperformance to age-related muscle support.
-
EIT Food Expands Reach to Foster Agrifood-Tech Start-ups in Latin America
2023-11-17The European Institute of lnnovation and Technology (ElT), partnering with FoodtechHUB Latam, is expanding its Food Accelerator Network (FAN) to Brazil, where it willopen a hub that will help develop burgeoning agrifood-tech start-ups in the LatinAmerica.
-
EPA Pressures Minnesota to Tackle Nitrate Threat in Drinking Water
2023-11-15The U.S. Environmental Protection Agency (EPA) has issued a letter to the Government of Minnesota requiring the state to address dangerous levels of nitrate contamination in its drinking water.
-
FDA Proposes Nationwide Ban on Brominated Vegetable Oil (BVO) in Food Additives, Continues Safety Assessment of Chemicals
2023-11-13On November 2, 2023, the U.S. Food and Drug Administration (FDA) proposed to ban the use of related food additives (brominated vegetable oil, BVO) and continue to evaluate the safety of other chemical substances.
-
Exploring International Dietary Supplement Regulations: A Comprehensive Analysis of Dosage Forms and Approved Functional Ingredients in Key Markets
2023-11-10In recent years, as people pay more attention to health and nutrition, dietary supplements have become an important part of many people's daily lives.
Hot News
-
ECHEMI平台投诉处罚规则 - ECHEMI platform complaint penalty rules
-
ECHEMI平台禁限售商品目录规则 - Announcement on the list of prohibited sales of Prohibited and Controlled Items on ECHEMI
-
ECHEMI禁售商品发布规则 Rules for the Release of Prohibited Products on ECHEMI.com
-
From August 1st, many shipping companies charge high port congestion fees!
-
Congestion in 116 ports around the world! The increase in freight rates will continue into the first half of next year!
-
Semaglutide initiates Phase III clinical trial of NASH in China
-
GLP-1 competition: Semaglutide surpasses dulaglutide this year
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
Ecuador pesticides market: imports during 2022 reached 275.6 Mio USD and 53.5 Mio USD in Q1 2023
-
Styrene: Supply And Demand Change